Developing vaccines and antibodies using machine learning
Official title: Machine learning-enabled design of prototype pathogen vaccines and antibodies
Funded at University of Washington · NIH-10861405 · Data updated 2026-11-12
This study is working on new vaccines and treatments to help protect people from certain viruses, using advanced technology and teamwork among researchers, so that we can be better prepared for future outbreaks.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | August 12, 2024 |
| Project end | July 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $41,075,241 |
| NIH project number | 1U19AI181881-01 |
| Project ID | NIH-10861405 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals at risk of infection from bunyaviruses and paramyxoviruses, particularly during outbreaks.
✕Less likely to help
Patients who are not at risk for these specific viral infections may not receive any benefit from this research.
What this research studies
This research focuses on creating innovative vaccines and antibodies to combat emerging viral pathogens, specifically bunyaviruses and paramyxoviruses. By leveraging machine learning and computational protein design, the team aims to develop effective vaccine prototypes and biologics. The project involves collaboration among five research institutions, utilizing advanced techniques in structural biology and mRNA vaccine technology. Patients may benefit from the development of vaccines that are tailored to effectively target these viruses, enhancing pandemic preparedness.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines that protect against serious viral infections.
How similar studies have gone: Previous research has shown success in using computational methods for vaccine design, indicating a promising approach for this novel project.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: King, Neil — University of Washington
- Study coordinator: King, Neil
Related research
Other NIH-funded projects on the same topics.
-
Making genetic testing more accessible to the public
This study is all about making it easier for people at risk of certain cancers, like breast, ovarian, and colon cancers, to get genetic testing, so we can find out what helps them access these important services and understand how they can benefit from them.
-
Breast cancer diagnosis in low-resource settings using millifluidics and fast digital imaging in Ghana
A new project will test a fast, low-cost way to diagnose breast cancer at the point of care in Ghana using small-batch fluidics and direct digital imaging.
-
Binaural Hearing and Speech in Noise in Children
This project explores how children hear speech in noisy classrooms using how the two ears work together to see if binaural processing differences explain why some kids struggle more than others.
-
Neural circuits that control pain aversion in the brain
Researchers are exploring how a specific brain area helps people feel and avoid pain, with potential to lead to better pain treatments.
-
United World Antiviral Research Network (UWARN)
A collaborative, international effort is testing new virus surveillance and evolution ideas to help people living with HIV and communities in LMICs stay safer from current and emerging viruses.
-
HF endotypes in heart failure using ethical multi-modal AI and molecular data
A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.